February 22, 2001Cytomel Liothyronine (RX) Recall
Louis, MO (SafetyAlerts) - The Food
and Drug Administration (FDA) said today that Jones Pharma, Inc. is recalling
one lot of (Rx) Cytomel Liothyronine sodium tablets because of subpotency (@ 20 month of
This is the first public notice of
this Class II
recall issued by FDA.
(Rx) Cytomel Liothyronine sodium tablets, 25 MCG, bottles of 100.
Lot No. 549D16, Exp. 05/01.
Schering Canada, Inc., Pointe-Claire, Quebec H9R 1B4, Canada.
Jones Pharma, Inc., St. Louis, MO, by letter on 1/19/01. Firm-initiated recall ongoing.
Nationwide to wholesale distributors and physicians.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafetyAlerts subscribers February
22, 2001. For more information regarding the SafetyAlerts free email alert service
please click here.
comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn
consumers of faulty products and contaminated foods. For complete information regarding
current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.